The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
8-[(6-Aminopyridin-3-yl)oxy]-4,5-dihydrothieno[3,4-g][1,2]benzisothiazole-6-carboxamide ID: ALA4074204
PubChem CID: 126511850
Max Phase: Preclinical
Molecular Formula: C15H12N4O2S2
Molecular Weight: 344.42
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: NC(=O)c1sc(Oc2ccc(N)nc2)c2c1CCc1cnsc1-2
Standard InChI: InChI=1S/C15H12N4O2S2/c16-10-4-2-8(6-18-10)21-15-11-9(13(22-15)14(17)20)3-1-7-5-19-23-12(7)11/h2,4-6H,1,3H2,(H2,16,18)(H2,17,20)
Standard InChI Key: MIRNBYWEECOSRO-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 26 0 0 0 0 0 0 0 0999 V2000
8.8385 -7.4758 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.3799 -9.3427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0920 -9.7511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8040 -8.5177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8040 -9.3391 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5854 -9.5931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0683 -8.9285 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.5854 -8.2638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6475 -7.3076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3799 -8.5177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0920 -8.1009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9157 -7.2949 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
6.0946 -7.2134 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.7635 -7.9691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8403 -10.3779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2882 -10.9909 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.6473 -10.5494 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.1941 -7.9252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0025 -7.7575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2619 -6.9721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7069 -6.3541 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.9007 -6.5251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0696 -6.8030 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10 2 1 0
2 3 1 0
3 5 1 0
4 11 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 1 0
8 4 2 0
8 1 1 0
1 9 1 0
10 11 2 0
11 12 1 0
12 13 1 0
13 14 2 0
14 10 1 0
6 15 1 0
15 16 2 0
15 17 1 0
9 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 9 1 0
20 23 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 344.42Molecular Weight (Monoisotopic): 344.0402AlogP: 2.84#Rotatable Bonds: 3Polar Surface Area: 104.12Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.85CX Basic pKa: 5.92CX LogP: 2.13CX LogD: 2.11Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.76Np Likeness Score: -0.33
References 1. Ono K, Banno H, Okaniwa M, Hirayama T, Iwamura N, Hikichi Y, Murai S, Hasegawa M, Hasegawa Y, Yonemori K, Hata A, Aoyama K, Cary DR.. (2017) Design and synthesis of selective CDK8/19 dual inhibitors: Discovery of 4,5-dihydrothieno[3',4':3,4]benzo[1,2-d]isothiazole derivatives., 25 (8): [PMID:28302507 ] [10.1016/j.bmc.2017.02.038 ]